Careers at Guided Therapeutics

HomeLuVivaPipelinePublicationsInvestorsNewsContactE-mail

News Releases

Board of Directors

Audit Committee Charter

Compensation Committee Charter

Key People

Regulatory Filings

Stock Quote

 

  Board of Directors


Michael C. James, Managing Partner, Kuekenhof Capital Management, LLC, Chairman
Mr. James
has served as a member of our board of directors since March 2007. Mr. James is also the Managing Partner of Kuekenhof Capital Management, LLC, a private investment management company. He also holds the position of Managing Director of Kuekenhof Equity Fund, L.P. and Kuekenhof Partners, L.P. Mr. James currently sits on the Board of Directors of Millennium Biotechnologies Group, Inc.  Mr. James was Chief Executive Officer of Nestor, Inc. from January 2009 to September 2009.  He was on the Board of Directors of Nestor, Inc. from July 2006 to June 2009.  He was employed by Moore Capital Management, Inc., a private investment management company from 1995 to 1999 and held position of Partner. He was employed by Buffalo Partners, L.P., a private investment management company from 1991 to 1994 and held the position of Chief Financial and Administrative Officer. He was employed by National Discount Brokers from 1986 to 1991 and held positions of Treasurer and Chief Financial Officer. He began his career in 1980 as a staff accountant with Eisner LLP. Mr. James received a B.S. degree in Accounting from Fairleigh Dickinson University in 1980. He is chairman of the audit and compensation committees.


Ronald W. Hart, Ph.D., Vice Chairman
Dr. Hart has served as a member of Guided Therapeutics’ Board of Directors since March 2007.  He has published over 600 peer-reviewed publications.  In 1980, Dr. Hart was appointed Director of the National Center for Toxicological Research, the research arm of the FDA, a position he held until 1992.  In 1992, Dr. Hart was the first ever Presidential Appointee to the position of Distinguished Scientist in Residence for the U.S. Public Health Service/FDA, a position he held until his retirement in 2000.  Dr. Hart currently serves on the Boards of Directors of Motor Excellence, St. Renatus, SNTech, Inc., AeroFarms, Inc., and GeoTherm, Inc., and has helped in the development of business strategy for a number of start-up companies. He is chairman of the nomination committee.


John E. Imhoff, M.D., Southeast Eye Center (Formally Imhoff Eye Center)

Dr. Imhoff has served as a member of our Board of Directors since April 2006.  Dr. Imhoff is an ophthalmic surgeon who specializes in cataract and refractive surgery.  He presently serves as a member of the Hawaiian Eye Foundation’s Scientific Advisory Board.  He is also one of our principal shareholders and invests in many other private and public companies.  He has a B.S. in Industrial Engineering from Oklahoma State University, an M.D. from the University of Oklahoma and completed his ophthalmic residency at the Dean A. McGee Eye Institute. He has worked as an ophthalmic surgeon and owner of Southeast Eye Center since 1983. He serves on the compensation and audit committees.


Jonathan M. Niloff, M.D., MedVentive, Inc.

Dr. Niloff has served as a director since May 2010.  As Chief Medical Officer of MedVentive since 2000, Dr. Niloff is responsible for the overall performance and strategic direction of that company. He is currently an Associate Professor of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School. Prior to joining MedVentive, Dr. Niloff served as President of the Beth Israel Deaconess Physicians Organization, Medical Director for Obstetrics and Gynecology for its Affiliated Physicians Group, and Chief of Gynecology at New England Deaconess Hospital. He has deep expertise in all aspects of medical cost and quality improvement, and has published extensively on the topic of gynecologic oncology including the development of the CA125 test for ovarian cancer. Dr. Niloff received his undergraduate education at The Johns Hopkins University, an MD degree from McGill University, and an MBA degree from Boston University. He serves on the audit committee.


Linda Rosenstock, M.D., M.P.H., Dean Emeritus of the University of California, Los Angeles (UCLA) Fielding School of Public Health

Dr. Rosenstock was appointed to the board in April 2012. In addition to the position of Dean, she holds appointments as Professor of Medicine and Environmental Health Sciences and is a recognized authority in broad areas of public health and science policy. Before coming to UCLA in 2000, Dr. Rosenstock served as Director of the National Institute for Occupational Safety and Health (NIOSH) for nearly seven years.  As Director of NIOSH, Dr. Rosenstock led the only federal agency with a mandate to undertake research and prevention activities in occupational safety and health.  During her tenure, she was instrumental in creating the National Occupational Research Agenda, a framework for guiding occupational safety and health research and in expanding the agency's responsibilities.  In recognition of her efforts, Dr. Rosenstock received the Presidential Distinguished Executive Rank Award, the highest executive service award in the government and was also the James P. Keogh Award Winner for 2011, in appreciation of a lifetime of extraordinary leadership in occupational health and safety. Dr. Rosenstock received her M.D. and M.P.H. from The Johns Hopkins University.  She conducted her advanced training at the University of Washington, where she was Chief Resident in Primary Care Internal Medicine and a Robert Wood Johnson Clinical Scholar. Internationally, Dr. Rosenstock has been active in teaching and research in many developing countries and has served as an advisor to the World Health Organization.  Dr. Rosenstock also chaired the United Auto Workers/General Motors Occupational Health Advisory Board.  She is an Honorary Fellow of the Royal College of Physicians and an elected member of the National Academy of Sciences' Institute of Medicine, where she has served as a member of their Board on Health Sciences Policy and Chair of the Committee for Preventive Services for Women.  In January, 2011, she was appointed by President Barrack Obama to the Advisory Group on Prevention, Health Promotion and Integrative and Public Health.


Gene Cartwright, Chief Executive Officer

Mr. Cartwright was appointed CEO and to the board of directors in January 2014. He brings over 30 years of experience working in the In vitro diagnostics industry. He joins Guided Therapeutics from Omnyx, LLC, a Joint Venture between GE Healthcare and the
University of Pittsburgh Medical Center, where, as CEO for over four years he founded and managed the successful development of products for the field of Digital Pathology. Prior to his work with Omnyx, LLC, he was President of Molecular Diagnostics for GE Healthcare.

Before joining GE, he was Divisional Vice President/General Manager for Abbott Diagnostics’ Molecular Diagnostics business. In his 24 year career at Abbott, he also served as Divisional Vice President for U.S. Marketing for five years.He received a Masters of Management degree from Northwestern’s Kellogg School of Management and also holds a Ph.D. in chemistry from Stanford University and an AB from Dartmouth College.


Mark L. Faupel, Ph.D., Chief Scientific Officer
Dr. Faupel has more than 25 years of experience as a senior executive developing non-invasive alternatives to surgical biopsies and blood tests, especially in the area of cancer screening and diagnostics. Prior to coming to SpectRx in 1998 as Vice President of Business Development and then co-founding Guided Therapeutics, Dr. Faupel was a senior executive and co-founder of Biofield Corp. He is the inventor on 20 U.S. patents and author of numerous scientific publications and presentations, appearing in such peer-reviewed journals as The Lancet, Cancer, The European Journal of Radiology and Diabetes Technology & Therapeutics. He has served as a member of the European School of Oncology Task Force and on National Institutes of Health review panels.  Dr. Faupel earned his Ph.D. in neuroanatomy and physiology from the University of Georgia.

 


©2014 Guided Therapeutics, Inc.

5835 Peachtree Corners East

Suite D

Norcross, GA 30092

770-242-8723

770-242-8639 - Fax

www.guidedinc.com

info@guidedinc.com

Terms of Service

cheap jordans sport blue 6s lebron 12 jordan 3 sport blue louis vuitton outlet jordan 11 legend blue louis vuitton outlet sport blue 3s louis vuitton outlet Lebron 11 louis vuitton outlet louis vuitton outlet michael kors outlet Louis Vuitton Outlet retro jordans for sale kate spade outlet nike kd vii sport blue 6s Louis Vuitton Outlet louis vuitton outlet